James Baldwin, MD
Clinical Professor of Internal Medicine
Clinical Professor of Mary H Weiser Food Allergy and Section Head
Division of Allergy
Medical School
Email:
[email protected]
Available to mentor
James Baldwin, MD
Clinical Professor
Manage Your Profile
Recent Publications
-
2026 Jul 27;PresentationAspirin Exacerbated Respiratory Disease
-
Greenhawt M, Dribin TE, Abrams EM, Shaker M, Chu DK, Golden DBK, Akin C, Anagnostou A, ALMuhizi F, Alqurashi W, Arkwright P, Baldwin JL, Banerji A, Bégin P, Ben-Shoshan M, Bernstein J, Bingemann TA, Bindslev-Jensen C, Blumenthal K, Byrne A, Cahill J, Cameron S, Campbell D, Campbell R, Cavender M, Chan ES, Chinthrajah S, Comberiati P, Eastman JJ, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Garvey LH, Grayson MH, Isabwe GAC, Hartog N, Hendron D, Horner CC, Hourihane JOB, Iglesia E, Kan M, Kaplan B, Katelaris CH, Kim H, Kelso JM, Khan DA, Lang D, Ledford D, Levin M, Lieberman JA, Loh R, Mack DP, Mazer B, Mody K, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Nathan R, Oppenheimer J, Otani IM, Park M, Pawankar R, Perrett KP, Peter J, Phillips EJ, Picard M, Pitlick M, Ramsey A, Rasmussen TH, Rathkopf MM, Reddy H, Robertson K, Rodriguez del Rio P, Sample S, Sheshadri A, Sheik J, Sindher SB, Spergel JM, Stone CA, Stukus D, Tang MLK, Tracy JM, Turner PJ, Vander Leek TK, Wallace DV, Wang J, Wasserman S, Weldon D, Wolfson AR, Worm M, Yacoub MR. Journal of Allergy and Clinical Immunology, 2023 Aug 1; 152 (2): 309 - 325.Journal ArticleUpdated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
DOI:10.1016/j.jaci.2023.05.019 PMID: 37295474 -
O'Shea K, Schuler C, Chen J, Troost J, Wong P, Chen K, O'Shea D, Peng W, Gherasim C, Manthei D, Valdez R, Baldwin J, Baker JR. Frontiers in Immunology, 2023 Jan 31;Journal ArticleWild-type-induced SARS-CoV-2 neutralizing immunity decreases across variants and time and correlates with clinical testing
-
O'Shea DR, Schuler C, Chen J, Troost JP, Wong P, Gherasim C, Manthei DM, Valdez R, Baldwin J, O'Shea K, Baker J. 2023 Feb 3;Proceeding / Abstract / PosterInfection and Vaccination with Wild Type SARS-CoV-2 Leads to the Highest Neutralizing Antibody Levels Against Variants
-
O’Shea D, Schuler C, Chen J, Troost J, Wong P, Chen K, Peng W, Gherasim C, Manthei D, Valdez R, Baldwin J, O'Shea K, Baker J. The Journal of allergy and clinical immunology, 2023 Feb 8; 151 (2): AB24 - AB24.Proceeding / Abstract / PosterInfection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron
PMID: PMC9895900 -
O’Shea D, Schuler C, Chen J, Troost J, Wong P, Chen K, Peng W, Gherasim C, Manthei D, Valdez R, Baldwin J, O'Shea K, Baker J. Journal of Allergy and Clinical Immunology, 2023 Feb 5; 151 (2): ab24 - ab24.Proceeding / Abstract / PosterInfection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron
DOI:10.1016/j.jaci.2022.12.079 -
Chen K, O'Shea KM, Schuler CF, Chen J, Troost J, Wong P, O'Shea DR, Peng W, Gherasim C, Manthei D, Valdez R, Baldwin JL, Baker JR. 2023 Feb 24;Proceeding / Abstract / PosterInfection with wild type sars-CoV-2 combined with vaccination augments neutralizing antibody levels against variants including omicron
-
Chen K, O'Shea K, Schuler C, Chen J, Troost J, Wong P, O'Shea D, Peng W, Gherasim C, Manthei D, Valdez R, Baldwin J, Baker J. Journal of Allergy and Clinical Immunology, 2023 Feb 5; 151 (2): ab117 - ab117.Proceeding / Abstract / PosterViral Neutralization Against SARS-CoV-2 is More Durable After Infection Versus Vaccination
DOI:10.1016/j.jaci.2022.12.371